E
Acurx Pharmaceuticals, Inc. ACXP
$4.08 $0.225.70% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 40.23% 26.03% 3.26% -29.18% -27.22%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -58.60% -34.12% -8.78% 23.05% 34.36%
Change in Net Operating Assets -692.11% -116.76% -71.90% -100.84% -99.86%
Cash from Operations 33.28% 14.26% -5.94% -73.71% -70.27%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -16.76% -59.80% -18.96% 211.57% 30.54%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -16.76% -59.80% -18.96% 211.57% 30.54%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 89.34% -345.51% -130.08% 63.72% -5,295.90%